Joyce Meghan V. sold $728K of GH
Joyce Meghan V. sold 5,728 shares of Guardant Health, Inc. (GH) at $127.11 ($0.73M total) on 2026-06-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The market may briefly react to insider selling, but 10b5-1 scheduling typically limits interpretability as new negative information.
Market read
A disclosed director sale in GH, executed under a pre-arranged plan, is more sentiment/positioning data than a fundamental catalyst.
What to watch
The filing does not disclose reasons for sale; without follow-on buys/sells or changes in other insiders, the trading signal is weak.
Background
SEC Form 4 reports insider transactions; this one is an open-market sale by a director under a Rule 10b5-1 plan.
Ticker impact
Guardant Health director Joyce Meghan V. sold 5,728 shares in an open-market transaction disclosed via SEC Form 4.
Likely limited near-term impact; any effect is more about sentiment than fundamentals.
Insider sales can be interpreted as bearish, but 10b5-1 plans are typically scheduled and not necessarily tied to new information.
Market effects
Minimal; this is company-specific insider activity with no stated operational or regulatory change.
None indicated.
None indicated.
Counterpoint
Because the sale was executed under a pre-arranged 10b5-1 plan, it may reflect routine liquidity rather than a view on prospects.
Key entities
- issuerGuardant Health, Inc.
Subject of the insider transaction disclosure (director sale under 10b5-1).
- insiderJoyce Meghan V.
Director who sold shares; filing is the source of the disclosed transaction details.
